litlas
Log inCreate account

Lawrence F. Eichenfield

Active 1997–2025

Also published as
Lawrence F Eichenfield
171
Papers
20,547
Citations
81
h-index
152
i10-index

Citations

Citations per year for Lawrence F. Eichenfield1962: 1 citations1980: 1 citations1986: 1 citations1999: 1 citations2000: 1 citations2001: 7 citations2002: 14 citations2003: 26 citations2004: 44 citations2005: 46 citations2006: 22 citations2007: 34 citations2008: 51 citations2009: 41 citations2010: 36 citations2011: 50 citations2012: 75 citations2013: 75 citations2014: 72 citations2015: 78 citations2016: 123 citations2017: 152 citations2018: 151 citations2019: 649 citations2020: 641 citations2021: 774 citations2022: 640 citations2023: 602 citations2024: 927 citations2025: 552 citations2026: 4 citations1963–1979: no citations, so these years are not shown1981–1985: no citations, so these years are not shown1987–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,928 citing papers, 23.8% of this breakdownGermany: 566 citing papers, 7% of this breakdownUnited Kingdom: 534 citing papers, 6.6% of this breakdownChina: 408 citing papers, 5.1% of this breakdownItaly: 408 citing papers, 5% of this breakdownCanada: 393 citing papers, 4.9% of this breakdownFrance: 307 citing papers, 3.8% of this breakdownJapan: 300 citing papers, 3.7% of this breakdownSpain: 251 citing papers, 3.1% of this breakdownNetherlands: 240 citing papers, 3% of this breakdownDenmark: 220 citing papers, 2.7% of this breakdownSwitzerland: 217 citing papers, 2.7% of this breakdown
0%23.8%Other 28.6%

Institutions

Fields

  • Medicine80%
  • Biochemistry, Genetics and Molecular Biology7.7%
  • Immunology and Microbiology6.2%
  • Neuroscience1.9%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Health Professions0.8%
  • Other2.4%

Topics

  • Dermatology and Skin Diseases17.9%
  • Allergic Rhinitis and Sensitization10.4%
  • Food Allergy and Anaphylaxis Research8.4%
  • Asthma and respiratory diseases6.6%
  • Psoriasis: Treatment and Pathogenesis6%
  • Urticaria and Related Conditions2.5%
  • Other48.2%

Coauthors

All papers

Open in search
  1. Management of Acne Vulgaris

    Authors: Dawn Z. Eichenfield, Jessica Sprague, Lawrence F. Eichenfield - JAMA 2021 cited by 361

  2. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

    Authors: Joshua A. Boyce, Amal Assa’ad, A Wesley Burks, Stacie M. Jones, Hugh A. Sampson, Robert A. Wood, Marshall Plaut, Susan F. Cooper, Matthew J. Fenton, Syed Hasan Arshad, Sami L. Bahna, Lisa A. Beck, Carol Byrd‐Bredbenner, Carlos A. Camargo, Lawrence F. Eichenfield, Glenn T. Furuta, Jon M. Hanifin, Carol Jones, Monica Kraft, Bruce D. Levy, Phil Lieberman, Stefano Luccioli, Kathleen M. McCall, Lynda C. Schneider, Ronald A. Simon, F. Estelle R. Simons, Stephen J. Teach, Barbara P. Yawn, Julie M. Schwaninger - Journal of Allergy and Clinical Immunology 2010 cited by 2,342

  3. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies

    Authors: Kim Papp, Jacek C. Szepietowski, Leon Kircik, Darryl Toth, Lawrence F. Eichenfield, Donald Y.M. Leung, Seth Forman, May E. Venturanza, Kang Sun, Michael E. Kuligowski, Eric L. Simpson - Journal of the American Academy of Dermatology 2021 cited by 297

  4. Guidelines of care for the management of atopic dermatitis

    Authors: Lawrence F. Eichenfield, Wynnis L. Tom, Sarah L. Chamlin, Steven R. Feldman, Jon M. Hanifin, Eric L. Simpson, Timothy G. Berger, James N. Bergman, David E. Cohen, Kevin D. Cooper, Kelly M. Cordoro, Dawn Marie R. Davis, Alfons Krol, David J. Margolis, Amy S. Paller, Kathryn Schwarzenberger, Robert A. Silverman, Hywel C Williams, Craig A. Elmets, Julie Block, Christopher G. Harrod, Wendy Smith Begolka, Robert Sidbury - Journal of the American Academy of Dermatology 2013 cited by 1,257

  5. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies

    Authors: Dawn Marie R. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, Robert Sidbury - Journal of the American Academy of Dermatology 2023 cited by 215

  6. Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis

    Authors: Emma Guttman‐Yassky, Andrew Blauvelt, Lawrence F. Eichenfield, Amy S. Paller, April W. Armstrong, Janice Drew, Ramanan Gopalan, Eric L. Simpson - JAMA Dermatology 2020 cited by 339

  7. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

    Authors: Amy S. Paller, Wynnis L. Tom, Mark Lebwohl, Robin L. Blumenthal, Mark Boguniewicz, Robert S. Call, Lawrence F. Eichenfield, Douglass W. Forsha, William C. Rees, Eric L. Simpson, Mary Spellman, Linda Stein Gold, Andrea L. Zaenglein, Matilda H. Hughes, Lee T. Zane, Adelaide A. Hebert - Journal of the American Academy of Dermatology 2016 cited by 565

  8. Guidelines of care for the management of atopic dermatitis in adults with topical therapies

    Authors: Robert Sidbury, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, Dawn Marie R. Davis - Journal of the American Academy of Dermatology 2023 cited by 182

  9. Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

    Authors: Kristian Reich, Kenji Kabashima, Ketty Peris, Jonathan I. Silverberg, Lawrence F. Eichenfield, Thomas Bieber, Aleksandra Kaszuba, Jill Kolodsick, Fan Emily Yang, Margaret Gamalo, Dennis Brinker, Amy M. DeLozier, Jonathan Janes, Fabio P. Nunes, Jacob P. Thyssen, Eric L. Simpson - JAMA Dermatology 2020 cited by 279

  10. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials

    Authors: Eric L. Simpson, J.‐P. Lacour, Lynda Spelman, Ricardo Galimberti, Lawrence F. Eichenfield, Robert Bissonnette, Brett King, Jacob P. Thyssen, Jonathan I. Silverberg, Thomas Bieber, Kenji Kabashima, Yuichiro Tsunemi, Antonio Costanzo, Emma Guttman‐Yassky, Lisa A. Beck, Jonathan Janes, Amy M. DeLozier, Margaret Gamalo, Dennis Brinker, T. Cardillo, Fabio P. Nunes, Amy S. Paller, Andreas Wollenberg, Kristian Reich - British Journal of Dermatology 2020 cited by 379

  11. Altered proliferation and networks in neural cells derived from idiopathic autistic individuals

    Authors: Maria C. Marchetto, Haim Belinson, Yuan Tian, Bruna Carolina Barbosa Freitas, Fuliang Cao, Krishna C. Vadodaria, Patrícia Cristina Baleeiro Beltrão-Braga, Cleber A. Trujillo, Ana P. D. Mendes, Krishnan Padmanabhan, Yanelli Nunez, Ou Jiang, Hiyaa S. Ghosh, Rebecca A. Wright, Kristen Brennand, Karen Pierce, Lawrence F. Eichenfield, Tiziano Pramparo, Lisa T. Eyler, Cynthia Carter Barnes, E Courchesne, Daniel H. Geschwind, Fred H. Gage, Anthony Wynshaw‐Boris, Alysson R. Muotri - Molecular Psychiatry 2016 cited by 503

  12. American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults

    Authors: Dawn Marie R. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Jonathan I. Silverberg, Anne Marie Singh, Robert Sidbury - Journal of the American Academy of Dermatology 2022 cited by 152

  13. Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)

    Authors: Antonio Torrelo, Barbara Rewerska, María Laura Galimberti, Amy S. Paller, Chin‐Yi Yang, Apurva Prakash, Danting Zhu, Marco Antônio Gonçalves Pontes Filho, Wen-Shuo Wu, Lawrence F. Eichenfield - British Journal of Dermatology 2023 cited by 86

  14. Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies

    Authors: Kim Papp, Jacek C. Szepietowski, Leon Kircik, Darryl Toth, Lawrence F. Eichenfield, Seth Forman, Michael E. Kuligowski, Howard Kallender, Kang Sun, Haobo Ren, Eric L. Simpson - Journal of the American Academy of Dermatology 2022 cited by 92

  15. Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

    Authors: Eric L. Simpson, Carsten Flohr, Lawrence F. Eichenfield, Thomas Bieber, Howard Sofen, Alain Taı̈eb, Ryan Owen, Wendy S. Putnam, Marcela Castro, Kendra DeBusk, Chin‐Yu Lin, Athina Voulgari, Karl Yen, Theodore A. Omachi - Journal of the American Academy of Dermatology 2018 cited by 329

  16. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders

    Authors: Amy S. Paller, Jennifer C. Jaworski, Eric L. Simpson, Mark Boguniewicz, John J. Russell, Julie Block, Susan Tofte, Jeffrey D. Dunn, Steven R. Feldman, Adele Clark, Gene Schwartz, Lawrence F. Eichenfield - American Journal of Clinical Dermatology 2018 cited by 267

  17. Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis

    Authors: Lawrence F. Eichenfield, Carsten Flohr, Robert Sidbury, Elaine C. Siegfried, Zsuzsanna Szalai, Ryszard Galus, Zhirong Yao, Hidetoshi Takahashi, S. Barbarot, Claire Feeney, Fan Zhang, Marco DiBonaventura, Ricardo Rojo, Hernán Valdez, Gary Chan - JAMA Dermatology 2021 cited by 162

  18. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

    Authors: Eric L. Simpson, Marjolein de Bruin‐Weller, Carsten Flohr, Michael R. Ardern‐Jones, S. Barbarot, Mette Deleuran, Thomas Bieber, Christian Vestergaard, Sara Brown, Michael J. Cork, Aaron M. Drucker, Lawrence F. Eichenfield, R. Foelster‐Holst, Emma Guttman‐Yassky, Audrey Nosbaum, Nick J. Reynolds, Jonathan I. Silverberg, Jochen Schmitt, Marieke M.B. Seyger, Phyllis I. Spuls, Jean-Francois Stalder, John Su, Roberto Takaoka, Claudia Traidl‐Hoffmann, Jacob P. Thyssen, Jorien van der Schaft, Andreas Wollenberg, Alan D. Irvine, Amy S. Paller - Journal of the American Academy of Dermatology 2017 cited by 236

  19. Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials

    Authors: Jonathan I. Silverberg, Lawrence F. Eichenfield, Adelaide A. Hebert, Eric L. Simpson, Linda Stein Gold, Robert Bissonnette, Kim Papp, John Browning, Pearl Kwong, Neil J. Korman, Philip M. Brown, David S. Rubenstein, Stephen C. Piscitelli, Matthew C. Somerville, Anna M. Tallman, Leon Kircik - Journal of the American Academy of Dermatology 2024 cited by 86

  20. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

    Authors: Eric L. Simpson, Robert Bissonnette, Lawrence F. Eichenfield, Emma Guttman‐Yassky, Brett King, Jonathan I. Silverberg, Lisa A. Beck, Thomas Bieber, Kristian Reich, Kenji Kabashima, Marieke M.B. Seyger, Elaine C. Siegfried, Georg Stingl, Steven R. Feldman, Alan Menter, Peter van de Kerkhof, Gil Yosipovitch, C. Paul, Philippe Martel, Ariane Dubost-Brama, John Armstrong, Rajeev Chavda, Steve Frey, Y. Joubert, M. Milutinovic, Anne Parneix, Henrique D. Teixeira, Chen-Yen Lin, Luna Sun, Paul Klekotka, Brian J. Nickoloff, Yves Dutronc, Lotus Mallbris, Jonathan Janes, Amy M. DeLozier, Fabio P. Nunes, Amy S. Paller - Journal of the American Academy of Dermatology 2020 cited by 178

  21. Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting

    Authors: Lawrence F. Eichenfield, Stephen Stripling, Selwyn Fung, Amy Cha, Andryann O’Brien, Lawrence A. Schachner - Pediatric Drugs 2022 cited by 104

  22. Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study

    Authors: Amy S. Paller, Carsten Flohr, Lawrence F. Eichenfield, Alan D. Irvine, Jamie Weisman, Jennifer Soung, Ana Pinto Correia, Chitra R Natalie, Claudia Rodriguez Capriles, Evangeline Pierce, Sarah A. Reifeis, Renata Gontijo Lima, Clara Armengol Tubau, Vivian Laquer, Stephan Weidinger - Dermatology and Therapy 2023 cited by 44

  23. Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies

    Authors: Mark Boguniewicz, Andrew Alexis, Lisa A. Beck, Julie Block, Lawrence F. Eichenfield, Luz Fonacier, Emma Guttman‐Yassky, Amy S. Paller, David M. Pariser, Jonathan I. Silverberg, Mark Lebwohl - The Journal of Allergy and Clinical Immunology In Practice 2017 cited by 192

  24. Atopic dermatitis: pathogenesis

    Authors: Emma Guttman‐Yassky, Andrea Waldman, Jusleen Ahluwalia, Peck Y. Ong, Lawrence F. Eichenfield - Seminars in Cutaneous Medicine and Surgery 2017 cited by 103